XML 43 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements (Tables)
9 Months Ended
Nov. 03, 2018
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis
The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis at November 3, 2018, October 28, 2017 and February 3, 2018. The Company did not have any transfers between Level 1, Level 2 or Level 3 during the thirty-nine weeks ended November 3, 2018 or October 28, 2017.   
 
 

 
Fair Value Measurements
($ thousands)
Total

 
Level 1

Level 2

Level 3

Asset (Liability)
 

 
 

 

 

November 3, 2018:
 
 
 
 
 
Cash equivalents – money market funds
$
56,668

 
$
56,668

$

$

Non-qualified deferred compensation plan assets
7,223

 
7,223



Non-qualified deferred compensation plan liabilities
(7,223
)
 
(7,223
)


Deferred compensation plan liabilities for non-employee directors
(2,772
)
 
(2,772
)


Restricted stock units for non-employee directors
(5,395
)
 
(5,395
)


Derivative financial instruments, net
(1,211
)
 

(1,211
)

Mandatory purchase obligation - Blowfish Malibu
(9,138
)
 


(9,138
)
October 28, 2017:
 
 
 
 
 
Cash equivalents – money market funds
$
14,967

 
$
14,967

$

$

Non-qualified deferred compensation plan assets
6,000

 
6,000



Non-qualified deferred compensation plan liabilities
(6,000
)
 
(6,000
)


Deferred compensation plan liabilities for non-employee directors
(2,350
)
 
(2,350
)


Restricted stock units for non-employee directors
(10,118
)
 
(10,118
)


Derivative financial instruments, net
196

 

196


February 3, 2018:
 
 
 
 
 
Cash equivalents – money market funds
$
53,106

 
$
53,106

$

$

Non-qualified deferred compensation plan assets
6,445

 
6,445



Non-qualified deferred compensation plan liabilities
(6,445
)
 
(6,445
)


Deferred compensation plan liabilities for non-employee directors
(2,289
)
 
(2,289
)


Restricted stock units for non-employee directors
(4,343
)
 
(4,343
)


Derivative financial instruments, net
998

 

998


Schedule of Impairment Charges by Segment
This assessment resulted in the following impairment charges, primarily for leasehold improvements and furniture and fixtures in the Company's retail stores, which were included in selling and administrative expenses for the respective periods.

 
Thirteen Weeks Ended
Thirty-Nine Weeks Ended
($ thousands)
November 3, 2018

October 28, 2017

November 3, 2018

October 28, 2017

Impairment Charges
 
 
 
 
Famous Footwear
$
150

$
150

$
450

$
450

Brand Portfolio
957

726

1,590

2,545

Total impairment charges
$
1,107

$
876

$
2,040

$
2,995

Schedule of Fair Value of Financial Instruments
The fair values of cash and cash equivalents (excluding money market funds discussed above), receivables and trade accounts payable approximate their carrying values due to the short-term nature of these instruments.

The carrying amounts and fair values of the Company's other financial instruments subject to fair value disclosures are as follows:
 
November 3, 2018
 
October 28, 2017
 
February 3, 2018
 
Carrying

 
Fair

 
Carrying

 
Fair

 
Carrying

 
Fair

($ thousands)
Value

 
Value

 
Value

 
Value

 
Value

 
Value

Borrowings under revolving credit agreement
$
350,000

 
$
350,000

 
$
20,000

 
$
20,000

 
$

 
$

Long-term debt
197,817

 
203,500

 
197,348

 
209,000

 
197,472

 
210,000

Total debt
$
547,817


$
553,500


$
217,348


$
229,000


$
197,472


$
210,000